Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study

Marya D Zilberberg, Chureen Carter, Patrick Lefebvre, Monika Raut, Francis Vekeman, Mei Sheng Duh, Andrew F Shorr, Marya D Zilberberg, Chureen Carter, Patrick Lefebvre, Monika Raut, Francis Vekeman, Mei Sheng Duh, Andrew F Shorr

Abstract

Introduction: Recent data indicate that transfusion of packed red blood cells (pRBCs) may increase the risk for the development of acute respiratory distress syndrome (ARDS) in critically ill patients. Uncertainty remains regarding the strength of this relationship.

Methods: To quantify the association between transfusions and intensive care unit (ICU)-onset ARDS, we performed a cohort study within Crit, a multicenter, prospective, observational study of transfusion practice in the ICU which enrolled 4,892 critically ill patients in 284 ICUs in the United States. Diagnostic criteria for ARDS were prospectively defined, and we focused on subjects without ARDS at admission. The development of ARDS in the ICU served as the primary endpoint.

Results: Among the 4,730 patients without ARDS at admission, 246 (5.2%) developed ARDS in the ICU. At baseline, ARDS cases were younger, more likely to be in a surgical ICU, and more likely to be admitted with pneumonia or sepsis than controls without ARDS. Cases also were more likely to have a serum creatinine of greater than 2.0 mg/dl (23% versus 18%) and a serum albumin of less than or equal to 2.3 g/dl (54% versus 30%) and were more severely ill upon ICU admission as measured by either the APACHE II (Acute Physiology and Chronic Health Evaluation II) or SOFA (Sequential Organ Failure Assessment) score (p < 0.05 for all). Sixty-seven percent and 42% of cases and controls, respectively, had exposure to pRBC transfusions (p < 0.05), and the unadjusted odds ratio (OR) of developing ARDS in transfused patients was 2.74 (95% confidence interval [CI], 2.09 to 3.59; p < 0.0001) compared to those never transfused. After age, baseline severity of illness, admitting diagnosis, and process-of-care factors were adjusted for, the independent relationship between pRBC transfusions and ICU-onset ARDS remained significant (adjusted OR, 2.80; 95% CI, 1.90 to 4.12; p < 0.0001).

Conclusion: Development of ARDS after ICU admission is common, occurring in approximately 5% of critically ill patients. Transfusion of pRBCs is independently associated with the development of ARDS in the ICU.

Figures

Figure 1
Figure 1
Multivariate analysis of independent transfusion risk factor for acute respiratory distress syndrome (ARDS). After covariates were adjusted for, the amount of blood exposure remained statistically significantly associated with an increasing risk of developing ARDS. Adjusted odds ratios relative to no transfusion were as follows: 1 to 2 units, 2.25 (95% confidence interval [CI], 1.44 to 3.50); 3 to 4 units, 2.71 (95% CI, 1.58 to 4.65); and more than 4 units, 5.22 (95% CI, 3.12 to 8.74) (p < 0.05 for all). *Covariates adjusted for in the multivariate logistic model included age, admitting diagnosis, intensive care unit type, nutritional status, process of care, severity of illness, and laboratory data.

References

    1. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and outcomes of acute lung injury. N Engl J Med. 2005;353:1685–1693. doi: 10.1056/NEJMoa050333.
    1. Hudson LD, Milberg JA, Anardi D, Maunder RJ. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med. 1995;151:293–301.
    1. Pepe P, Potkin RT, Reus DH, Hudson LD, Carrico CJ. Clinical predictors of the adult respiratory distress syndrome. Am J Surg. 1982;144:124–130. doi: 10.1016/0002-9610(82)90612-2.
    1. Fowler AA, Hamman RF, Good JT, Benson KN, Baird M, Eberle DJ, Petty TL, Hyers TM. Adult respiratory distress syndrome: risk with common predispositions. Ann Intern Med. 1983;98:593–597.
    1. Moss M, Bucher B, Moore FA, Moore EE, Parsons PE. The role of chronic alcohol abuse in the development of acute respiratory distress syndrome in adults. JAMA. 1996;275:50–54. doi: 10.1001/jama.275.1.50.
    1. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion related acute lung injury. Transfusion. 1985;25:573–577. doi: 10.1046/j.1537-2995.1985.25686071434.x.
    1. Popovsky MA, Chaplin HC, Jr, Moore SB. Transfusion-related acute lung injury: a neglected, serious complication of hemotherapy. Transfusion. 1992;32:589–592. doi: 10.1046/j.1537-2995.1992.32692367207.x.
    1. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409–417. doi: 10.1056/NEJM199902113400601.
    1. Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, Christiani DC. Clinical predictors of and mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med. 2005;33:1191–1198. doi: 10.1097/01.CCM.0000165566.82925.14.
    1. Kahn JM, Caldwell EC, Deem S, Newell DW, Heckbert SR, Rubenfeld GD. Acute lung injury in patients with subarachnoid hemorrhage: incidence, risk factors, and outcome. Crit Care Med. 2006;34:196–202. doi: 10.1097/01.CCM.0000194540.44020.8E.
    1. Biedler AE, Schneider SO, Seyfert U, Rensing H, Grenner S, Girndt M, Bauer I, Bauer M. Impact of alloantigens and storage-associated factors on stimulated cytokine response in an in vitro model of blood transfusion. Anesthesiology. 2002;97:1102–1109. doi: 10.1097/00000542-200211000-00011.
    1. Fransen E, Maessen J, Dentener M, Senden N, Buurman W. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest. 1999;116:1233–1239. doi: 10.1378/chest.116.5.1233.
    1. Blajchman MA, Dzik S, Vamvakas EC, Sweeney J, Snyder EL. Clinical and molecular basis of transfusion-induced immunomodulation: summary of the proceedings of a state-of-the-art conference. Transfus Med Rev. 2001;15:108–135. doi: 10.1053/tmrv.2001.22614.
    1. Vamvakas EC. Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials. Transfusion. 1996;36:175–186. doi: 10.1046/j.1537-2995.1996.36296181932.x.
    1. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, MacIntyre NR, Shabot MM, Duh MS, Shapiro MJ. The CRIT Study: anemia and blood transfusion in the critically ill – current clinical practice in the United States. Crit Care Med. 2004;32:39–52. doi: 10.1097/01.CCM.0000104112.34142.79.
    1. Shapiro MJ, Gettinger A, Corwin HL, Napolitano L, Levy M, Abraham E, Fink MP, MacIntyre N, Pearl RG, Shabot MM. Anemia and blood transfusion in trauma patients admitted to the intensive care unit. J Trauma. 2003;55:269–273.
    1. Levy MM, Abraham E, Zilberberg M, MacIntyre NR. A descriptive evaluation of transfusion practices in patients receiving mechanical ventilation. Chest. 2005;127:928–935. doi: 10.1378/chest.127.3.928.
    1. Shorr AF, Duh MS, Kelly KM, Kollef MH, CRIT Study Group Red blood cell transfusion and ventilator-associated pneumonia: a potential link? Crit Care Med. 2004;32:666–674. doi: 10.1097/01.CCM.0000114810.30477.C3.
    1. Shorr AF, Jackson WL, Kelly KM, Fu M, Kollef MH. Transfusion practice and blood stream infections in critically ill patients. Chest. 2005;127:1722–1728. doi: 10.1378/chest.127.5.1722.
    1. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818–824.
    1. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–829. doi: 10.1097/00003246-198510000-00009.
    1. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–710.
    1. Kopko PM, Pagliaroni TG, Popovsky MA, Muto KN, MacKenzie MR, Holland PV. TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion. 2003;43:177–184. doi: 10.1046/j.1537-2995.2003.00307.x.
    1. Silliman CC, Paterson AJ, Dickey WO, Stroneck DF, Popovsky MA, Caldwell SA, Ambruso DR. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion. 1997;37:719–726. doi: 10.1046/j.1537-2995.1997.37797369448.x.
    1. Silliman CC, Voelkel NF, Allard JD, Elzi DJ, Tuder RM, Johnson JL, Ambruso DR. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1998;101:1458–1467.
    1. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, Clarke G, Ambruso DR. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood. 2003;101:454–462. doi: 10.1182/blood-2002-03-0958.
    1. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood. 2005;105:2266–2273. doi: 10.1182/blood-2004-07-2929.
    1. Kristiansson M, Soop M, Saraste L, Sundqvist KG. Cytokines in stored red blood cell concentrates: promoters of systemic inflammation and simulators of acute transfusion reactions? Acta Anaesthesiol Scand. 1996;40:496–501.
    1. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood. 2001;97:1180–1195. doi: 10.1182/blood.V97.5.1180.
    1. Lee TH, Stromberg RR, Heitman J, Tran K, Busch MP. Quantitation of residual white cells in filtered blood components by polymerase chain reaction amplification of HLA DQ-A DNA. Transfusion. 1994;34:986–994. doi: 10.1046/j.1537-2995.1994.341195065038.x.
    1. Taylor RW, Manganaro L, O'Brien J, Trottier SJ, Parkar N, Veremakis C. Impact of allogenic packed red blood cell transfusion on nosocomial infection rates in the critically ill patient. Crit Care Med. 2002;30:2249–2254. doi: 10.1097/00003246-200210000-00012.
    1. Taylor RW, O'Brien J, Trottier SJ, Manganaro L, Cytron M, Lesko MF, Arnzen K, Cappadoro C, Fu M, Plisco MS, et al. Red blood cell transfusions and nosocomial infections in critically ill patients. Crit Care Med. 2006;34:2302–2308. doi: 10.1097/01.CCM.0000234034.51040.7F.
    1. Earley AS, Gracias VH, Haut E, Sicoutris CP, Wiebe DJ, Reilly PM, Schwab CW. Anemia management program reduces transfusion volumes, incidence of ventilator-associated pneumonia, and cost in trauma patients. J Trauma. 2006;61:1–7.
    1. Carson JL, Altman DG, Duff A, Noveck H, Weinstein MP, Sonnenberg FA, Hudson JI, Provenzano G. Risk of bacterial infection associated with allogeneic blood transfusion among patients undergoing hip fracture repair. Transfusion. 1999;39:694–700. doi: 10.1046/j.1537-2995.1999.39070694.x.
    1. Houbiers JG, van de Velde CJ, van de Watering LM, Hermans J, Schreuder S, Bijnen AB, Pahlplatz P, Schattenkerk ME, Wobbes T, de Vries JE, et al. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion. 1997;37:126–134. doi: 10.1046/j.1537-2995.1997.37297203513.x.
    1. Koval KJ, Rosenberg AD, Zuckerman JD, Aharonoff GB, Skovron ML, Bernstein RL, Su E, Chakka M. Does blood transfusion increase the risk of infection after hip fracture? J Orthop Trauma. 1997;11:260–265. doi: 10.1097/00005131-199705000-00004.
    1. Vamvakas EC, Carven JH. Allogeneic blood transfusion, hospital charges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med. 1998;122:145–151.
    1. Claridge JA, Sawyer RG, Schulman AM, McLemore EC, Young JS. Blood transfusions correlate with infections in trauma patients in a dose-dependent manner. Am Surg. 2002;68:566–572.
    1. Rubenfeld GD, Caldwell E, Granton J, Hudson LD, Matthay MA. Interobserver variability in applying a radiographic definition for ARDS. Chest. 1999;116:1347–1353. doi: 10.1378/chest.116.5.1347.
    1. Meade MO, Cook DJ, Guyatt GH, Groll R, Kachura JR, Bedard M, Cook DJ, Slutsky AS, Stewart TE. Interobserver variation in interpreting chest radiographs for the diagnosis of acute respiratory distress syndrome. Am J Respir Crit Care Med. 2000;161:85–90.
    1. Nathens AB, Nester TA, Rubenfeld GD, Nirula R, Gernsheimer TB. The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trial. Shock. 2006;26:342–347. doi: 10.1097/01.shk.0000228171.32587.a1.
    1. Hébert PC, Fergusson D, Blajchman MA, Wells GA, Kmetic A, Coyle D, Heddle N, Germain M, Goldman M, Toye B, Leukoreduction Study Investigators et al. Clinical outcomes following institution of the Canadian universal reduction program for red blood transfusions. JAMA. 2003;289:1941–1949. doi: 10.1001/jama.289.15.1941.
    1. Watkins TR, Rubenfeld GD, Martin TR, Caldwell E, Nathens AB. Effects of leukoreduced blood transfusion on acute lung injury in trauma patients: a randomized controlled trial [abstract] Proc Am Thoracic Soc. 2006;3:A301.
    1. Izbicki G, Rudensky B, Na'amad M, Hershko C, Huerta M, Hersch M. Transfusion-related leukocytosis in critically ill patients. Crit Care Med. 2004;32:439–442. doi: 10.1097/01.CCM.0000104951.94820.A9.
    1. van Hilten JA, van de Watering LMG, van Bockel JH, van de Velde CJ, Kievit J, Brand R, van den Hout WB, Geelkerken RH, Roumen RM, Wesselink RM, et al. Effects of transfusion with red cells filtered to remove leucocytes: randomized controlled trial in patients undergoing major surgery. BMJ. 2004;328:1281–1288. doi: 10.1136/bmj.38103.735266.55.

Source: PubMed

3
Abonneren